insigHT2021, the region’s leading medical travel market intelligence conference featured the launch of Malaysia as the Hepatitis C Treatment Hub of Asia by Minister of Health Malaysia, Khairy Jamaluddin.
Being the first country in the world to be given conditional approval for Ravidasvir in combination with Sofosbuvir to treat Hepatitis C, Malaysia is poised to offer access to an affordable and efficacious treatment solution for those infected with the virus.
“In response to the World Hepatitis Day 2021 theme, “Hepatitis Can’t Wait”, Malaysia is ready and raring to move forward with a treatment solution for those infected with the disease. This is in line with WHO’s mission to reduce new viral hepatitis infections by 90% and reduce deaths by viral hepatitis by 65% by 2030. Malaysia is offering Hepatitis C patients a treatment with a cure rate of 97% and cost reduction of 95%,” said YB Khairy Jamaluddin, Minister of Health Malaysia at the insigHT2021 opening ceremony.
Commenting on this new treatment offering, Pharmaniaga Berhad Group Managing Director Datuk Zulkarnain Md Eusope added, “Through our expertise in the supply, logistics and distribution of Hepatitis-C Drug to MHTC’s Member Hospitals, we are proud to contribute to the shared goal of both Malaysia and World Health Organisation to eliminate Hepatitis-C by 2030. In creating access to treatment for local and international patients in need, we partner in the vision of Forging Resilience, further propelling the medical travel industry forward.”
insigHT2021 is hosted virtually from November 16 to 18 and is anchored by Malaysia Healthcare Travel Council (MHTC), an agency under the Ministry of Health tasked to facilitate and promote the healthcare travel industry in Malaysia. Carrying the theme ‘Forging Resilience’, the conference features insights on post-pandemic recovery strategies and opportunities for industry resilience with topics such as reimaging the health system, the future of healthcare and well-being, and rebuilding hospitality delivered by renowned local and international industry experts.
In its sixth installation, insigHT2021 also serves as a catalyst for cross-collaboration, attracting industry players across various sectors of the value chain to enhance Malaysia’s healthcare travel industry. TMOne, the digital partner for insigHT2021 has played an instrumental role in driving digitalisation of key touchpoints along the healthcare travel journey.
insigHT2021 attracts a global crowd of participants from Asia and Europe and features a lineup of speakers, comprising of global thought leaders and experts in the field of medical travel.
insigHT2021 is supported by TM One (Digital Partner), Tourism Malaysia, Tourism Selangor, IMM Carehub, and Magicopper.
